Modern approaches to preventive and therapeutic use of probiotics in infectious diseases in pediatric practice
Abstract
Probiotics (living microorganisms that, when administered in adequate quantities, have a beneficial effect on health) have gained a well-deserved popularity in the medical environment and the broad strata of the non-medical population over the last two decades, due to their high efficacy, proven in well-organized clinical trials. This publication reflects modern approaches to the use of probiotics in the treatment of infectious diarrhea in children, the preventive use of probiotics to prevent the occurrence of antibiotic-associated diarrhea and respiratory infections in pediatric practice.
About the Authors
I. V. Andreeva
Smolensk State Mesical University
Russian Federation
Russian Federation
E. V. Dovgan
Smolensk Regional Clinical Hospital
Russian Federation
Russian Federation
O. U. Stetsyuk
Smolensk State Mesical University
Russian Federation
Russian Federation
References
1. Lilly DM, Stillwell RH. Probiotics: Growth-Promoting Factors Produced by Microorganisms. Science 1965,147:747-748.
2. R.B. P. Probiotics, the other half of the antibiotic story. Anim. Nutr. Health 1974,29:4-8.
3. Reid G. Regulatory and clinical aspects of dairy probiotics. FAO/WHO Expert Consultation o nEvaluation of Health and Nutritiona Properties of Powder Milk with Live Lactic Acid Bacteria. Cordoba, Argentina. 2001:1-34.
4. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003,16:658-672.
5. Probiotics Pros and Cons. In; 2014.
6. Мирзоян А. Про биотики и не только. Обзор рынка пробиотиков по итогам 1-го полугодия 2016 года. Фармацевтический вестник 2016,33(862):18-19.
7. Lee YK, Salminen S. Handbook of Probiotics and Prebiotics, 2nd Edition: Wiley; 2009.
8. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 2006,6:374-382.
9. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 2001,33 Suppl 2: S 17-25.
10. Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002,109:678-684.
11. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002,47:2625-2634.
12. Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev: CD 003048. Медицинский алфавит № 19 / 2017, том № 2. Практическая гастроэнтерология E-mail: medalfavit@mail.ru
13. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 2000,30:54-60.
14. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 1994,344:1046-1049.
15. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 1995,14:107-111.
16. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children - updated analysis of randomised controlled trials. Aliment Pharmacol Ther,38:467-476.
17. La Rosa M, Bottaro G, Gulino N, Gambuzza F, Di Forti F, Ini G, et al. [Prevention of antibiotic-associated diarrhea with Lactobacillus sporogens and fructo-oligosaccharides in children. A multicentric double-blind vs placebo study]. Minerva Pediatr 2003,55:447-452.
18. McFarland LV. Epidemiology, risk factors and treatments for antibiotic-associated diarrhea. Dig D'is 1998,16:292-307.
19. Castagliuolo I, Riegler MF, Valenick L, LaMont JT, Pothoulakis C. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infect Immun 1999,67:302-307.
20. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. BMJ 2002,324:1361.
21. Arvola T, Laiho K, Torkkeli S, Mykkanen H, Salminen S, Maunula L, et al. Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections: a randomized study. Pediatrics 1999,104: e64.
22. Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr 1999,135:564-568.
23. Jirapinyo P, Densupsoontorn N, Thamonsiri N, Wongarn R. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002,85 Suppl 2: S739-742.
24. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2015: CD 004827.
25. Lau CS, Chamberlain RS. Probiotics are effective at preventing Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Int J Gen Med 2016,9:27-37.
26. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA,307:1959-1969.
27. McFarland LV. Deciphering meta-analytic results: a mini-review of probiotics for the prevention of paediatric antibiotic-associated diarrhoea and Clostridium difficile infections. Benef Microbes 2015,6:189-194.
28. Nafstad P, Hagen JA, Oie L, Magnus P, Jaakkola JJ. Day care centers and respiratory health. Pediatrics 1999,103:753-758.
29. Stojkovic A, Simovic A, Bogdanovic Z, Bankovic D, Poskurica M. Clinical trial/experimental study (consort compliant): Optimal time period to achieve the effects on synbiotic-controlled wheezing and respiratory infections in young children. Srp Arh Celok Lek 2016,144:38-45.
30. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 2001,322:1327.
31. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr 2010,29:312-316.
32. Rautava S, Salminen S, Isolauri E. Specific probiotics in reducing the risk of acute infections in infancy - a randomised, double-blind, placebo-controlled study. Br J Nutr 2009,101:1722-1726.
Review
For citations:
Andreeva I.V., Dovgan E.V., Stetsyuk O.U. Modern approaches to preventive and therapeutic use of probiotics in infectious diseases in pediatric practice. Medical alphabet. 2017;2(19):16-21. (In Russ.)
Views:
236
Email this article 